The experimental results showed that knocking down RFX5 significantly inhibited the volume and mass of HCC tumors in mice, while further overexpression of STIL reversed the inhibitory effect (Figure 6A,B). The gene discussed is RFX5; the disease is hepatocellular carcinoma.